Jvj Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 20-12-2024
- Paid Up Capital ₹ 0.50 M
as on 20-12-2024
- Company Age 21 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.41 M
as on 20-12-2024
- Satisfied Charges ₹ 6.50 M
as on 20-12-2024
- Revenue 11.53%
(FY 2020)
- Profit -4531.11%
(FY 2020)
- Ebitda -50.96%
(FY 2020)
- Net Worth -176.09%
(FY 2020)
- Total Assets -11.14%
(FY 2020)
About Jvj Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹9.41 M. The company has closed loans amounting to ₹6.50 M, as per Ministry of Corporate Affairs (MCA) records.
Jyoti Jain and Vikas Jain serve as directors at the Company.
- CIN/LLPIN
U24232MP2002PTC015479
- Company No.
015479
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Dec 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jvj Pharmaceuticals Private Limited offer?
Jvj Pharmaceuticals Private Limited offers a wide range of products and services, including Skin Care, Facewash.
Who are the key members and board of directors at Jvj Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Jain  | Director | 31-Dec-2002 | Current |
| Jyoti Jain | Director | 31-Dec-2002 | Current |
Financial Performance of Jvj Pharmaceuticals.
Jvj Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 11.53% increase. The company also saw a substantial fall in profitability, with a 4531.11% decrease in profit. The company's net worth observed a substantial decline by a decrease of 176.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jvj Pharmaceuticals?
In 2019, Jvj Pharmaceuticals had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Feb 2024 | ₹2.72 M | Open |
Yes Bank Limited Creation Date: 31 May 2022 | ₹0.83 M | Open |
Yes Bank Limited Creation Date: 25 Feb 2016 | ₹5.86 M | Open |
How Many Employees Work at Jvj Pharmaceuticals?
Jvj Pharmaceuticals has a workforce of 28 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jvj Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jvj Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
